Systematic recording of medication adherence in patients with obsessive-compulsive disorder

• Conditions: F42; Obsessive-compulsive disorder

• Registration Number: DRKS00015462
• Lead Sponsor: Klinik und Poliklinik für Psychiatrie und Psychotherapie Universitätsklinikum Leipzig

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2019-01-31
• Study Completion: 2020-02-03
• Results First Posted: 2021-12-13
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Diagnosis of obsessive-compulsive disorder, sufficient knowledge of German, sufficient vision and reading ability

Exclusion Criteria

Age under 18 years, no obsessive-compulsive disorder

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Measurement of medication adherence using a questionnaire. Included are elements of MARS, DAI10, Universal Stigma Scale, OCI-R, GAF.

Secondary Outcome Measures

Name	Time	Method
Re-measurement of medication adherence using a questionnaire 6 months after the first data collection. Included are elements of MARS, DAI10, Universal Stigma Scale, OCI-R, GAF. In addition, drug levels measured in serum during regular treatment will be evaluated.